NASDAQ:AURA | Free Cash Flow | Aura Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$29.89M$102,000.00-$30M
2025-12-31-$20.47M$176,000.00-$20.65M
2025-03-31-$23.36M$187,000.00-$23.54M
2024-12-31-$23.95M$299,000.00-$24.25M
2024-03-31-$24.45M$88,000.00-$24.54M
2023-12-31-$17.39M$317,000.00-$17.7M
2023-03-31-$16.41M$109,000.00-$16.52M
2022-12-31-$18.01M$358,000.00-$18.37M
2022-03-31-$15.2M$599,000.00-$15.8M
2021-12-31-$12.09M$819,000.00-$12.91M
2021-03-31-$5.14M$71,000.00-$5.21M
2020-12-31-$3.76M$132,000.00-$3.89M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$84.74M$447,000.00-$85.19M
2024-12-31-$79.81M$1.25M-$81.06M
2023-12-31-$63.85M$709,000.00-$64.56M
2022-12-31-$54.6M$1.09M-$55.7M
2021-12-31-$32.41M$2.13M-$34.54M
2020-12-31-$24.32M$771,000.00-$25.09M